IDT expands commercial scale pharmaceutical manufacturing

IDT Australia*,(Institute of Drug Technology Limited) recently installed their new Avestin EmulsiFlex C55. With a flow rate of up to 55L/hr, this system bridges the gap between a benchtop and production scale high pressure homogeniser that can be applied to cell disruption (Bacteria, Yeast, Algae, Insect and Mammalian cells), liposomal products, emulsions and particle size reduction. A unique “dynamic” homogenising valve and no “O”-rings or gaskets in the entire path of the product, means less risk for contamination or blockage. The C55 is versatile in terms of suitable sample sizes, processing a minimum sample volume of only 100mL and allowing for adjustable flow rates down to ~18L/hr and temperature control. The system is suitable for GMP compliance as well as compliance to 21 CFR Part 11. *IDT is an Australian cGMP pharmaceutical manufacturing company that specialises in high containment, high potency manufacture of Active Pharmaceutical Ingredients (API) and Finished Dose Forms (FDF), as well as offering a full suite of contract manufacturing services.  For more information on the Avestin range and accessories, please contact us below: Contact us for more information     Other popular high pressure homogenisers used to efficiently reduce particles and droplets from micron to nanometer sizes include:   Avestin Emulsiflex C5 is a lab scale, air driven, high pressure homogeniser.   Avestin Emulsiflex C3 is a lab scale, electric motor driven, high pressure homogeniser.

Request a call back Request sample testing Request service or support